Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator

Clinical trials are increasingly focused on pre-manifest and early Alzheimer’s disease (AD). Accurately predicting clinical progressions from normal to MCI or from MCI to dementia/AD versus non-progression is challenging. Accurate identification of symptomatic progressors is important to avoid unnec...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Y., Kukull, W., Sano, M., Albin, R.L., Shen, C., Zhou, J., Dodge, H.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033942/
https://www.ncbi.nlm.nih.gov/pubmed/36946457
http://dx.doi.org/10.14283/jpad.2023.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033942/
https://www.ncbi.nlm.nih.gov/pubmed/36946457
http://dx.doi.org/10.14283/jpad.2023.10

Ejemplares similares